References
- Jaanus S. D., Pagano V. T., Bartlett J. D. Drugs affecting the autonomic nervous system: cholinergic antagonists. “Clinical Ocular Pharmacology”, J. D. Bartlett. Butterworth Publishers, Boston 1984; 106–130
- Gambill H. D., Ogle K. N., Kearns T. P. Mydriatic effects of four drugs determined with a pupillograph. Arch. Ophthalmol. 1967; 77: 740–746
- Gettes B. C., Belmont O. Tropicamide: comparative cycloplegic effects. Arch. Ophthalmol. 1961; 66: 336–340
- Hammer R. H., Amin K., Gunes Z. E., Brouillette G., Bodor N. Novel soft anticholinergic agents. Drug Des. Deliv. 1988; 2: 207–219
- Weiner N. Atropine, scopolamine and related antimuscarinic drugs. “The Pharmacological Basis of Therapeutics”, A. G. Gilman, L. S. Goodman, A. Gilman. Macmillan, New York 1980; 6: 120–137
- Bodor N. Novel approaches to the design of safer drugs: soft drugs and site-specific chemical delivery systems. “Advances in Drug Research”, B. Testa. Academic Press, New York 1984; Vol. 13: 255–331
- Bodor N., Oshiro Y., Loftsson T., Katovich M., Caldwell M. Soft drugs 6. The application of the inactive metabolite approach for design of soft 8-blockers. Pharm. Res. 1984; 1: 120–125